NO20016252L - Fremgangsmåte for nedregulering av GDF-8 aktivitet - Google Patents
Fremgangsmåte for nedregulering av GDF-8 aktivitetInfo
- Publication number
- NO20016252L NO20016252L NO20016252A NO20016252A NO20016252L NO 20016252 L NO20016252 L NO 20016252L NO 20016252 A NO20016252 A NO 20016252A NO 20016252 A NO20016252 A NO 20016252A NO 20016252 L NO20016252 L NO 20016252L
- Authority
- NO
- Norway
- Prior art keywords
- gdf
- regulation
- activity
- procedure
- Prior art date
Links
- 102000004472 Myostatin Human genes 0.000 title 1
- 108010056852 Myostatin Proteins 0.000 title 1
- 230000003828 downregulation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Control Of Eletrric Generators (AREA)
- Debugging And Monitoring (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901014 | 1999-07-20 | ||
US14527599P | 1999-07-26 | 1999-07-26 | |
PCT/DK2000/000413 WO2001005820A2 (en) | 1999-07-20 | 2000-07-20 | Method for down-regulating gdf-8 activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20016252D0 NO20016252D0 (no) | 2001-12-19 |
NO20016252L true NO20016252L (no) | 2002-03-15 |
Family
ID=26065065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20016252A NO20016252L (no) | 1999-07-20 | 2001-12-19 | Fremgangsmåte for nedregulering av GDF-8 aktivitet |
Country Status (21)
Country | Link |
---|---|
US (2) | US7056512B1 (ru) |
EP (1) | EP1200119A2 (ru) |
JP (1) | JP2003506325A (ru) |
KR (1) | KR100750695B1 (ru) |
CN (1) | CN1384757A (ru) |
AU (1) | AU778470B2 (ru) |
CA (1) | CA2379852A1 (ru) |
EA (1) | EA005248B1 (ru) |
EE (1) | EE200200025A (ru) |
HK (1) | HK1048937A1 (ru) |
HR (1) | HRP20010900A2 (ru) |
HU (1) | HUP0201861A3 (ru) |
IL (1) | IL146845A0 (ru) |
MX (1) | MXPA01013232A (ru) |
NO (1) | NO20016252L (ru) |
NZ (1) | NZ517058A (ru) |
PL (1) | PL353855A1 (ru) |
SK (1) | SK722002A3 (ru) |
TR (2) | TR200200133T2 (ru) |
WO (1) | WO2001005820A2 (ru) |
ZA (1) | ZA200109901B (ru) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7393682B1 (en) * | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
US6369201B1 (en) | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
WO1999056768A1 (en) * | 1998-05-06 | 1999-11-11 | Metamorphix, Inc. | Methods for treating diabetes by inhibiting gdf-8 |
US7037501B2 (en) | 2001-01-04 | 2006-05-02 | Regents Of The University Of Minnesota | Myostatin immnoconjugate |
TW200526779A (en) | 2001-02-08 | 2005-08-16 | Wyeth Corp | Modified and stabilized GDF propeptides and uses thereof |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
WO2004019975A2 (en) * | 2002-08-30 | 2004-03-11 | Glaxo Group Limited | Il-14 vaccine for the treatment of asthma and atopic disorders |
AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
US7511012B2 (en) * | 2002-12-20 | 2009-03-31 | Amgen Inc. | Myostatin binding agents |
UA85055C2 (ru) | 2003-06-02 | 2008-12-25 | Уайт | Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний |
ITMI20071072A1 (it) | 2007-05-25 | 2008-11-26 | Lps Electronics S R L | Apparecchiatura per la rilevazione automatica dello stato di calore di una scrofa. |
KR20060120229A (ko) * | 2003-12-31 | 2006-11-24 | 쉐링-프라우 리미티드 | 중화 에피토프계 성장 증진 백신 |
JP4688483B2 (ja) | 2004-04-15 | 2011-05-25 | 株式会社テクノネットワーク四国 | フォリスタチン変異体ポリペプチド |
CA2582940A1 (en) | 2004-09-30 | 2006-04-06 | Orico Limited | Myostatin isoform |
CN101379086B (zh) | 2005-08-19 | 2013-07-17 | 惠氏公司 | 抗gdf-8的拮抗剂抗体以及在als和其他gdf-8-相关病症治疗中的用途 |
CN100450545C (zh) * | 2006-08-03 | 2009-01-14 | 中国医学科学院基础医学研究所 | 肌肉生长抑制素在制备抗肿瘤药物中的应用 |
AU2007279456A1 (en) | 2006-08-03 | 2008-02-07 | Myostin Therapeutics Pty Ltd | Myostatin antagonists |
GB0715087D0 (en) | 2007-08-03 | 2007-09-12 | Summit Corp Plc | Drug combinations for the treatment of duchenne muscular dystrophy |
JP2010535708A (ja) | 2007-08-03 | 2010-11-25 | ビオマリン アイジーエー リミテッド | デュシェンヌ型筋ジストロフィーの治療のための薬物併用 |
KR100857861B1 (ko) * | 2007-10-15 | 2008-09-11 | 주식회사 바이오리더스 | Myo-2 펩타이드 중합체와 마이오스타틴의 융합단백질표면발현용 벡터 및 상기 벡터로 형질전환된 미생물 |
JO3340B1 (ar) | 2010-05-26 | 2019-03-13 | Regeneron Pharma | مضادات حيوية لـعامل تمايز النمو 8 البشري |
WO2013003983A1 (zh) * | 2011-07-06 | 2013-01-10 | 湖北省农业科学院畜牧兽医研究所 | 猪肌抑素基因座位及其应用 |
PT2780368T (pt) | 2011-11-14 | 2018-03-22 | Regeneron Pharma | Composições e métodos para aumentar a massa muscular e a força muscular antagonizando especificamente gdf8 e/ou activina a |
JP6433889B2 (ja) | 2012-06-15 | 2018-12-05 | ファイザー・インク | Gdf−8に対する改善された拮抗抗体およびその使用 |
PT2880053T (pt) | 2012-08-01 | 2020-05-22 | Ikaika Therapeutics Llc | Mitigação de fibrose e danos de tecidos por anticorpo antiltbp4 |
LT2981822T (lt) | 2013-05-06 | 2020-12-28 | Scholar Rock, Inc. | Kompozicijos ir būdai, skirti augimo faktoriaus moduliacijai |
TWI655207B (zh) | 2013-07-30 | 2019-04-01 | 再生元醫藥公司 | 抗活化素a之抗體及其用途 |
EP2960653A1 (en) * | 2014-06-24 | 2015-12-30 | Stichting Kwaliteitsgarantie Vleeskalversector | Diagnostic kit and method for the identification of the manipulation of muscle mass in a domestic animal |
WO2016168613A1 (en) | 2015-04-15 | 2016-10-20 | Regeneron Pharmaceuticals, Inc. | Methods of increasing strength and functionality with gdf8 inhibitors |
US11248044B2 (en) | 2018-03-01 | 2022-02-15 | Regeneron Pharmaceuticals, Inc. | Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor |
EP3897689A1 (en) | 2018-12-21 | 2021-10-27 | Northwestern University | Use of annexins in preventing and treating muscle membrane injury |
WO2020139977A1 (en) | 2018-12-26 | 2020-07-02 | Northwestern University | Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6607884B1 (en) | 1993-03-19 | 2003-08-19 | The Johns Hopkins University School Of Medicine | Methods of detecting growth differentiation factor-8 |
DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
JP3926839B2 (ja) | 1993-09-14 | 2007-06-06 | エピミューン,インコーポレイティド | 万能dr−結合性ペプチドを用いる免疫応答の改変 |
AUPO390396A0 (en) | 1996-11-29 | 1996-12-19 | Csl Limited | Novel promiscuous T helper cell epitopes |
PL194221B1 (pl) | 1997-04-15 | 2007-05-31 | Pharmexa As | Zmodyfikowana cząsteczka ludzkiego TNFalfa, dimery, oligomery lub multimery zmodyfikowanej cząsteczki ludzkiego TNFalfa, wyizolowana cząsteczka DNA, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania zmodyfikowanej cząsteczki ludzkiego TNFalfa, szczepionki przeciwko TNFalfa oraz zastosowanie przynajmniej jednej zmodyfikowanej cząsteczki ludzkiego TNFalfa |
DE69841139D1 (de) * | 1997-07-14 | 2009-10-22 | Univ Liege | Mutationen im myostatingen steigern muskelmasse in säugetieren |
EP1038016A2 (en) * | 1997-12-16 | 2000-09-27 | Valentis Inc. | Needle-free injection of formulated nucleic acid molecules |
GB2333706A (en) * | 1998-02-02 | 1999-08-04 | Merck & Co Inc | Method for increasing muscle mass in animals |
US6369201B1 (en) | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
-
2000
- 2000-07-20 EA EA200200182A patent/EA005248B1/ru not_active IP Right Cessation
- 2000-07-20 CN CN00810614A patent/CN1384757A/zh active Pending
- 2000-07-20 US US09/620,586 patent/US7056512B1/en not_active Expired - Fee Related
- 2000-07-20 EE EEP200200025A patent/EE200200025A/xx unknown
- 2000-07-20 IL IL14684500A patent/IL146845A0/xx unknown
- 2000-07-20 HU HU0201861A patent/HUP0201861A3/hu unknown
- 2000-07-20 TR TR2002/00133T patent/TR200200133T2/xx unknown
- 2000-07-20 CA CA002379852A patent/CA2379852A1/en not_active Abandoned
- 2000-07-20 PL PL00353855A patent/PL353855A1/xx unknown
- 2000-07-20 EP EP00945671A patent/EP1200119A2/en not_active Withdrawn
- 2000-07-20 JP JP2001511477A patent/JP2003506325A/ja active Pending
- 2000-07-20 AU AU59675/00A patent/AU778470B2/en not_active Ceased
- 2000-07-20 NZ NZ517058A patent/NZ517058A/en unknown
- 2000-07-20 US US10/031,342 patent/US7070784B1/en not_active Expired - Fee Related
- 2000-07-20 WO PCT/DK2000/000413 patent/WO2001005820A2/en active IP Right Grant
- 2000-07-20 SK SK72-2002A patent/SK722002A3/sk unknown
- 2000-07-20 KR KR1020027000866A patent/KR100750695B1/ko not_active IP Right Cessation
- 2000-07-20 TR TR2004/00621T patent/TR200400621T2/xx unknown
- 2000-07-20 MX MXPA01013232A patent/MXPA01013232A/es active IP Right Grant
-
2001
- 2001-11-30 ZA ZA200109901A patent/ZA200109901B/xx unknown
- 2001-12-04 HR HR20010900A patent/HRP20010900A2/hr not_active Application Discontinuation
- 2001-12-19 NO NO20016252A patent/NO20016252L/no not_active Application Discontinuation
-
2003
- 2003-02-17 HK HK03101114.6A patent/HK1048937A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EE200200025A (et) | 2003-04-15 |
KR100750695B1 (ko) | 2007-08-22 |
TR200200133T2 (tr) | 2002-05-21 |
NZ517058A (en) | 2004-04-30 |
HUP0201861A3 (en) | 2004-07-28 |
HRP20010900A2 (en) | 2003-08-31 |
JP2003506325A (ja) | 2003-02-18 |
TR200400621T2 (tr) | 2004-08-23 |
SK722002A3 (en) | 2003-02-04 |
CN1384757A (zh) | 2002-12-11 |
US7070784B1 (en) | 2006-07-04 |
AU778470B2 (en) | 2004-12-09 |
MXPA01013232A (es) | 2005-05-24 |
HK1048937A1 (zh) | 2003-04-25 |
ZA200109901B (en) | 2003-05-28 |
US7056512B1 (en) | 2006-06-06 |
NO20016252D0 (no) | 2001-12-19 |
AU5967500A (en) | 2001-02-05 |
CA2379852A1 (en) | 2001-01-25 |
EP1200119A2 (en) | 2002-05-02 |
WO2001005820A2 (en) | 2001-01-25 |
EA005248B1 (ru) | 2004-12-30 |
IL146845A0 (en) | 2002-07-25 |
WO2001005820A3 (en) | 2001-07-19 |
PL353855A1 (en) | 2003-12-01 |
KR20020026544A (ko) | 2002-04-10 |
HUP0201861A2 (en) | 2002-09-28 |
EA200200182A1 (ru) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20016252L (no) | Fremgangsmåte for nedregulering av GDF-8 aktivitet | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
DE60028307D1 (de) | Eliminierung von interferenzsignalen | |
NO20014535L (no) | Inhibitorer av IMPDH-enzym | |
NO20010844D0 (no) | Regulering av substrataktivitet | |
NO20021474D0 (no) | Forbindelser for behandling av ischemi | |
PT1210113E (pt) | Composicoes de vacinas de combinacao | |
HUP0002224A3 (en) | Benzimidazole derivatives of antivirus activity | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20020365L (no) | Oligonukleotider for inhibiering av ekspresjonen av humant eg5 | |
NO20013507L (no) | Blandinger for behandling av inflammatoriske reaksjoner | |
PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
ID24677A (id) | Kombinasi senyawa aktif fungisidal | |
DE60010553D1 (de) | Interferenzunterdrückungsverfahren | |
NO20006279D0 (no) | Generator for produksjon av fotonantalltilstand | |
PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
PT1175417E (pt) | Compostos substituidos de benzolactamas | |
NO20014845D0 (no) | Anvendelse av arylalkanoylpyridaziner | |
NO20014026D0 (no) | Krampestillende derivater til behandling av betydelig skjelving | |
FR2790597B1 (fr) | Integration de condensateurs | |
NO20022157D0 (no) | Fremgangsmåte for behandling av medikamentavhengighet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |